Although numerous studies have demonstrated the critical role of MLKL in the progression of hemorrhagic stroke (Huang et al., 2022; Xu H. et al., 2021), there is currently no evidence to suggest that MLKL can serve as a drug target for alleviating hemorrhagic stroke. The gene discussed is MLKL; the disease is hemorrhagic stroke.